Pharmacotherapy
December 2010
Study Objective: To identify predictors of persistent posttransplant anemia that appear within the first week after kidney transplantation in order to determine the high-risk patients who might receive the most benefit from erythropoiesis-stimulating agents.
Study Design: Retrospective cohort study.
Setting: University-affiliated hospital and outpatient clinic.